Description
This training will review the available evidence for the use of medications to treat stimulant use disorders in patients who can become pregnant. The session will emphasize the importance of shared-decision making with pregnant patients to optimize outcomes related to stimulant use disorders and medication interventions.
Objectives
Following this training, participants will have the knowledge to:
-
Identify medications used to treat cocaine use disorder in pregnant patients.
-
Identify medications used to treat methamphetamine use disorder in pregnant patients.
-
Discuss the importance of collaborative decision-making in working with pregnant patients with stimulant use disorders interested in medication interventions.
Sponsored by
Boston Medical Center Grayken Center for Addiction TTA
Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Accreditation information
Please read the Accreditation Information section of the training page to learn about the requirements for receiving credit or a certificate of completion.
Audience
Providers, nurses, peer supports, other clinical staff, and non-clinicians.
